PCN16 COST-EFFECTIVENESS OF SORAFENIB VERSUS BEST SUPPORTIVE CARE IN ADVANCED RENAL CELL CARCINOMA IN SPAIN
Nov 1, 2006, 00:00
10.1016/S1098-3015(10)63446-8
https://www.valueinhealthjournal.com/article/S1098-3015(10)63446-8/fulltext
Title :
PCN16 COST-EFFECTIVENESS OF SORAFENIB VERSUS BEST SUPPORTIVE CARE IN ADVANCED RENAL CELL CARCINOMA IN SPAIN
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)63446-8&doi=10.1016/S1098-3015(10)63446-8
First page :
Section Title :
Open access? :
No
Section Order :
297